No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study

FP Vleggaar; Henk van Buuren; GP van Berge Henegouwen; null Hop; KJ van Erpecum

doi:10.1097/00042737-200102000-00013

No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study

FP Vleggaar, Henk van Buuren, GP van Berge Henegouwen, Hop, KJ van Erpecum

Research output: Contribution to journal › Article › Academic › peer-review

37 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	171-175
Number of pages	5
Journal	European Journal of Gastroenterology & Hepatology
Volume	13
DOIs	https://doi.org/10.1097/00042737-200102000-00013
Publication status	Published - 2001

Research programs

EMC MM-04-20-02-A
EMC NIHES-01-64-03

Access to Document

10.1097/00042737-200102000-00013

http://hdl.handle.net/1765/65662

Cite this

Vleggaar, FP., van Buuren, H., van Berge Henegouwen, GP., Hop, & van Erpecum, KJ. (2001). No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study. European Journal of Gastroenterology & Hepatology, 13, 171-175. https://doi.org/10.1097/00042737-200102000-00013

@article{16f2addb25cb4a65a9bd6c1ed3a2ed88,

title = "No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study",

author = "FP Vleggaar and {van Buuren}, Henk and {van Berge Henegouwen}, GP and Hop and {van Erpecum}, KJ",

year = "2001",

doi = "10.1097/00042737-200102000-00013",

language = "Undefined/Unknown",

volume = "13",

pages = "171--175",

journal = "European Journal of Gastroenterology & Hepatology",

issn = "0954-691X",

publisher = "Lippincott Williams & Wilkins",

}

Vleggaar, FP, van Buuren, H, van Berge Henegouwen, GP, Hop & van Erpecum, KJ 2001, 'No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study', European Journal of Gastroenterology & Hepatology, vol. 13, pp. 171-175. https://doi.org/10.1097/00042737-200102000-00013

No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study. / Vleggaar, FP; van Buuren, Henk; van Berge Henegouwen, GP et al.
In: European Journal of Gastroenterology & Hepatology, Vol. 13, 2001, p. 171-175.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study

AU - Vleggaar, FP

AU - van Buuren, Henk

AU - van Berge Henegouwen, GP

AU - Hop, null

AU - van Erpecum, KJ

PY - 2001

Y1 - 2001

U2 - 10.1097/00042737-200102000-00013

DO - 10.1097/00042737-200102000-00013

M3 - Article

SN - 0954-691X

VL - 13

SP - 171

EP - 175

JO - European Journal of Gastroenterology & Hepatology

JF - European Journal of Gastroenterology & Hepatology

ER -